Gujarat Themis Biosyn Limited has issued a regulatory disclosure regarding an upcoming board meeting scheduled for September 1, 2026. The primary agenda of the board meeting is to consider and approve raising funds through the issuance of equity shares and/or convertible warrants via a preferential issue on a private placement basis.
The fundraising will be conducted in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013. The approval is subject to obtaining necessary approvals from shareholders of the company and relevant stock exchanges.
In compliance with the company's Code of Conduct for Monitoring and Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's equity shares remains closed for all designated persons and their immediate relatives. The trading window closure will continue until 48 hours after the outcome of the board meeting is officially announced.
The disclosure was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's Corporate Identification Number is L24230GJ1981PLC004878, with registered office and factory located at 69/C GIDC Industrial Estate, Vapi - 396 195, Dist. Valsad, Gujarat, India.